Clinical TrialsSearch results
Number of results: 541
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Exploratory analysis of predictive and prognostic biomarkers in the randomized phase III study of FOLFOX plus bevacizumab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (WJOG4407GTR)
- metastatic colorectal cancer
- West Japan Oncology Group
- 2009-06-02
Other
- Lung Cancer Evaluation of TS-1 Study
- Previously untreated stageIIIB/IV NSCLC
- West Japan Oncology Group
- 2006-10-18
Other
- Phase I/II study of intermittent erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer
- Non-small cell lung cancer
- West Japan Oncology Group
- 2009-03-17
Other
- Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancer
- Previously untreated stageIIIB/IV NSCLC
- West Japan Oncology Group
- 2006-05-04
Other
- Phase II study of gefitinib in patients with EGFR mutation positive- advanced non-small cell lung cancer
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive disease small-cell lung cancer.
- extensive disease small-cell lung cancer
- West Japan Oncology Group
- 2005-09-05
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- Randomized phase II study of carboplatin / gemcitabine versus vinorelbine / gemcitabine in patients with advanced non-small cell lung cancer
- Stage IIIb/IV NSCLC
- West Japan Oncology Group
- 2005-09-02
Other
- Randomized phase II study of docetaxel plus zoledronic acid versus docetaxel in patients with relapsing or refractory non-small cell lung cancer and bone metastasis
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-03-26